EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics.
Saved in:
| Title: | EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics. |
|---|---|
| Authors: | Elborn JS; National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK. Electronic address: j.elborn@imperial.ac.uk., Ahuja S; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: sahuja@celtaxsys.com., Springman E; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: espringman@celtaxsys.com., Mershon J; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: jmershon@celtaxsys.com., Grosswald R; Celtaxsys, Inc., 201 17th St NW #530, Atlanta, GA, USA. Electronic address: rgrosswald@celtaxsys.com., Rowe SM; Departments of Medicine, Pediatrics, Cell Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA; Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: smrowe@uab.edu. |
| Source: | Contemporary clinical trials [Contemp Clin Trials] 2018 Sep; Vol. 72, pp. 86-94. Date of Electronic Publication: 2018 Jul 26. |
| Publication Type: | Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1559-2030 |
|---|---|
| DOI: | 10.1016/j.cct.2018.07.014 |
